SCHEMBL23731522

SCHEMBL23731522

Cc1ccc(C(=S)Sc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
HPGD P15428 1/20 0.43
POLB P06746 3/20 0.42
HSP90AA1 P07900 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CCR6 P51684 1/20 0.40
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253610 0.85 MAPT (0.40) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL10126426 0.82 CES2 (0.43) CES2MEN1KMT2AMAPTNPC1
SCHEMBL532899 0.81 ALDH1A1 (0.48) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL23731520 0.80 ALDH1A1 (0.41) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL23731523 0.80 MAPT (0.52) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL23731321 0.79 NPC1 (0.51) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL7516931 0.76 MAPT (0.32) MAPTHPGDSMN1; SMN2HDAC3HDAC4
SCHEMBL775576 0.76 NPC1 (0.64) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL23731519 0.76 ALDH1A1 (0.45) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL23731518 0.75 LTA4H (0.49) MEN1KMT2AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078157-B1 Compound embodiments that release H2S by reaction with a reactive compound and methods of making and using the same UNIVERSITY OF OREGON (US) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078157-B1 Compound embodiments that release H2S by reaction with a reactive compound and methods of making and using the same CBS, SQOR, QSOX1 CES2 213/4885CES1 2621/4885MEN1 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.